2025 biotech deals tracker: the latest partnerships and M&A activities

Biotech partnership deals in October

Explore the pulse of biotech deals on our dedicated page, featuring only the most notable news of 2025. We meticulously curate and categorize the latest collaborations and M&A activities, ensuring you stay informed about the most significant trends and strategic moves shaping the industry.

Looking for new funding opportunities and partnerships? Join Inpart’s global network of decision-makers and research teams seeking the latest assets, research, and expertise.

Biotech deals tracker: key moves in 2025

Tool: deals tracker

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

Get our 2025 biotech deals tracker in a Google Sheet—exclusive to Labiotech newsletter subscribers.

By clicking this I agree to receive Labiotech’s newsletter and understand that my personal data will be processed according to the Privacy Policy.*
Labiotech.eu

Where does the deals data on the Labiotech tracker come from?

At Labiotech, we focus on identifying biotech deals that truly matters. We combine two key approaches:

  1. News & press releases monitoring: We closely monitor the latest news and press releases, ensuring we only feature deals that could have a real impact on the industry.
  2. Specialized databases: We leverage trusted databases to identify the deals with the most promise.

Our editorial team organizes this information by deal type, the countries involved, the big pharma companies behind the deals, the technologies, the therapeutic areas, and other key factors.

In addition to our biotech deals tracker, we offer expert advice and trend articles to help you navigate the landscape. You can also explore past trackers to gain insights into how the funding landscape has evolved.

Check out these helpful resources: